Dengue incidence in urban and rural Cambodia: results from population-based active fever surveillance, 2006-2008

Sirenda Vong, Virak Khieu, Olivier Glass, Sowath Ly, Veasna Duong, Rekol Huy, Chantha Ngan, Ole Wichmann, G William Letson, Harold S Margolis, Philippe Buchy, Sirenda Vong, Virak Khieu, Olivier Glass, Sowath Ly, Veasna Duong, Rekol Huy, Chantha Ngan, Ole Wichmann, G William Letson, Harold S Margolis, Philippe Buchy

Abstract

Background: Dengue vaccines are now in late-stage development, and evaluation and robust estimates of dengue disease burden are needed to facilitate further development and introduction. In Cambodia, the national dengue case-definition only allows reporting of children less than 16 years of age, and little is known about dengue burden in rural areas and among older persons. To estimate the true burden of dengue in the largest province of Cambodia, Kampong Cham, we conducted community-based active dengue fever surveillance among the 0-to-19-year age group in rural villages and urban areas during 2006-2008.

Methods and findings: Active surveillance for febrile illness was conducted in 32 villages and 10 urban areas by mothers trained to use digital thermometers combined with weekly home visits to identify persons with fever. An investigation team visited families with febrile persons to obtain informed consent for participation in the follow-up study, which included collection of personal data and blood specimens. Dengue-related febrile illness was defined using molecular and serological testing of paired acute and convalescent blood samples. Over the three years of surveillance, 6,121 fever episodes were identified with 736 laboratory-confirmed dengue virus (DENV) infections for incidences of 13.4-57.8/1,000 person-seasons. Average incidence was highest among children less than 7 years of age (41.1/1,000 person-seasons) and lowest among the 16-to-19-year age group (11.3/1,000 person-seasons). The distribution of dengue was highly focal, with incidence rates in villages and urban areas ranging from 1.5-211.5/1,000 person-seasons (median 36.5). During a DENV-3 outbreak in 2007, rural areas were affected more than urban areas (incidence 71 vs. 17/1,000 person-seasons, p<0.001).

Conclusion: The large-scale active surveillance study for dengue fever in Cambodia found a higher disease incidence than reported to the national surveillance system, particularly in preschool children and that disease incidence was high in both rural and urban areas. It also confirmed the previously observed focal nature of dengue virus transmission.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1. Study sites and dengue incidences…
Figure 1. Study sites and dengue incidences by site and year, Kampong Cham province, Cambodia, 2006–2008.
Figure 2. Incidence of Febrile Illness and…
Figure 2. Incidence of Febrile Illness and Dengue Fever by Week, Kampong Cham Province, Cambodia, 2006–2008.
Figure 3. Dengue Incidence Rates by Age,…
Figure 3. Dengue Incidence Rates by Age, Kampong Cham Province, Cambodia, 2006–2008.

References

    1. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995;1:55–7.
    1. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003;27:1–13.
    1. Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis. 2006;12:887–93.
    1. Guzman MG, Kouri G. Dengue: An update. Lancet Infect Dis. 2002;2:33–42.
    1. Lang J. Recent progress on sanofi pasteur's dengue vaccine candidate. J Clin Virol. 2009;46(Suppl 2):S20–4.
    1. Morrison D, Legg TJ, Billings CW, Forrat R, Yoksan S, et al. A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults. J Infect Dis. 2010;201(3):370–7.
    1. DeRoeck D, Deen J, Clemens JD. Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four Southeast Asian countries. Vaccine. 2003;22:121–9.
    1. Mahoney RT, Krattiger A, Clemens JD, Curtiss R., 3rd The introduction of new vaccines into developing countries. IV: Global Access Strategies. Vaccine. 2007;25:4003–11.
    1. Huy R, Buchy P, Conan A, Ngan C, Ong S, et al. National dengue surveillance in Cambodia, 1980 - 2008: Insights on epidemiological and virological trends and impact of vector control interventions. Bull World Health Organ. 2010;88:650–7.
    1. Huy R, Wichmann O, Beatty M, Ngan C, Duong S, et al. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Pub Health. 2009;9:155.
    1. Chhour YM, Ruble G, Hong R, Minn K, Kdan Y, et al. Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian children. Emerg Infect Dis. 2002;8:485–9.
    1. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369:1452–59.
    1. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984;120:653–69.
    1. Burke DS, Nisalak A, Johnson DE, Scott RM. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg. 1988;38(1):172–80.
    1. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, et al. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg. 1999;61(3):412–9.
    1. Chareonsook O, Foy HM, Teeraratkul A, Silarug N. Changing epidemiology of dengue hemorrhagic fever in Thailand. Epidemiol Infect. 1999;122:161–6.
    1. Kumar A, Sharma SK, Padbidri VS, Thakare JP, Jain DC, et al. An outbreak of dengue fever in rural areas of northern India. J Commun Dis. 2001;33:274–81.
    1. Strickman D, Sithiprasasna R, Kittayapong P, Innis BL. Distribution of dengue and Japanese encephalitis among children in rural and suburban Thai villages. Am J Trop Med Hyg. 2000;63(1-2):27–35.
    1. Rossi CA, Ksiazek TG. Enzyme-linked immunosorbent assay (ELISA). In: Lee HW, Calisher C, Schmaljohn C, editors. Manual of hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Seoul: WHO Collaborating Center for Virus Reference and Research; 1998. pp. 87–91.
    1. Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, et al. Evaluation of commercially available anti-dengue virus Immunoglubulin M tests. Emerg Infect Dis. 2009;15:436–440.
    1. Buchy P, Vo VL, Bui KT, Trinh TX, Glaziou P, et al. Secondary dengue virus type 4 infections in Vietnam. Southeast Asian J Trop Med Public Health. 2005;36(1):178–85.
    1. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992;30(3):545–51.
    1. Reynes JM, Ong S, Mey C, Ngan C, Hoyer S, Sall AA. Improved molecular detection of dengue virus serotype 1 variants. J Clin Microbiol. 2003;41:3864–3867.
    1. Gubler DJ. Application of serotype-specific monoclonal antibodies for identification of dengue viruses. In: Yunker C, editor. Arboviruses and arthropod cells in vitro. Boca Raton: CRC Press; 1986. pp. 3–14.
    1. Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol. 2002;156(1):40–51.
    1. Yoksan S, Tubthong K, Kanitwithayanun W, Jirakanjanakit N. Laboratory assays and field dengue vaccine evaluation at Ratchaburi province, Thailand: a preliminary result. J Clin Virol. 2009;46(Suppl 2):S13–5.
    1. Tien NT, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VT, et al. Prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg. 2010;104(9):592–600.
    1. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg. 2005;72(1):60–6.
    1. Morrison AC, Minnick SL, Rocha C, Forshey BM, Stoddard ST, et al. Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis. 2010;4(5):e670.
    1. Kuan G, Gordon A, Avilés W, Ortega O, Hammond SN, et al. The Nicaraguan Pediatric Dengue Cohort Study: Study Design, Methods, Use of Information Technology, and Extension to Other Infectious Diseases. Am J Epidemiol. 2009;170(1):120–9.
    1. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, et al. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis. 2010;201(1):5–14.
    1. Kourí G, Guzmán MG, Valdés L, Carbonel I, del Rosario D, et al. Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba. Emerg Infect Dis. 1998;4(1):89–92.
    1. Peláez O, Guzmán MG, Kourí G, Pérez R, San Martín JL, et al. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis. 2004;10(4):719–22.
    1. Rocha C, Morrison AC, Forshey BM, Blair PJ, Olson JG, et al. Comparison of two active surveillance programs for the detection of clinical dengue cases in Iquitos, Peru. Am J Trop Med Hyg. 2009;80(4):656–60.
    1. National Institute of Public Health, National Institute of Statistics [Cambodia] and ORC Macro. Cambodia demographic and health survey 2005. 2006. Available: .
    1. Chanama S, Anantapreecha S, A-nuegoonpipat A, Sa-gnasang A, Kurane I, et al. Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J Clin Virol. 2004;31:185–9.
    1. Kay B, Nam VS. New strategy against Aedes aegypti in Vietnam. Lancet. 2005;365:613–17.
    1. Socheat D, Chanta N, Setha T, Hoyer S, Chang MS, et al. The development and testing of water storage jar covers in Cambodia. Dengue Bull. 2004;28:6–12. Available: .
    1. Mammen MP, Pimgate C, Koenraadt CJ, Rothman AL, Aldstadt J, et al. Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med. 2008;5:e205.
    1. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000;181:2–9.
    1. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, et al. Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis. 2010;4(3):e617.
    1. Gibbons RV, Kalanarooj S, Jarman RG, Nisalak A, Vaughn DW, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg. 2007;77:910–3.
    1. Carlos CC, Oishi K, Cinco MT, Mapua CA, Inoue S, et al. Comparison of clinical features and hematologic abnormalities between dengue fever and dengue hemorrhagic fever among children in the Philippines. Am J Trop Med Hyg. 2005;73:435–40.
    1. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg. 2003;68:191–202.
    1. Scott TW, Morrison AC. Aedes aegypti density and the risk of dengue virus transmission. In: Takken W, Scott TW, editors. Ecological aspects for application of genetically modified mosquitoes. Dordrecht, The Nederlands: FRONTIS; 2003. pp. 187–206.
    1. Kuno G. Review of the factors modulating dengue transmission. Epidemiol Rev. 1995;17:321–35.
    1. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, et al. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology. 1997;230:244–51.
    1. Adams B, Holmes EC, Zhang C, Mammen MP, Jr, Nimmannitya S, et al. Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci USA. 2006;103:14234–9.
    1. Hombach J. Guidelines for clinical trials of dengue vaccine in endemic areas. J Clin Virol. 2009;46(Suppl 2):S7–9.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa